+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Digital Respiratory Devices Market: Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

  • ID: 4790744
  • Report
  • Region: Global
  • 179 Pages
  • BIS Research
1 of 6

FEATURED COMPANIES

  • 3M Health Care Limited
  • Adherium Limited
  • AstraZeneca plc
  • Cohero Health
  • GlaxoSmithKline plc
  • Novartis AG
  • MORE

Key Questions Answered in the Report:

  • What was the total revenue generated by the global digital respiratory system market in 2018 and how is it expected to grow during 2019-2029?
  • What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?
  • What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?
  • What are the potential business models in global digital respiratory devices market?
  • Which product type, such as sensors & apps and smart inhalers & nebulizers of the global digital respiratory system market is expected to dominate during the forecast period from 2019-2029?
  • Which indication type such as asthma and chronic obstructive pulmonary disease of the global digital respiratory system market is expected to dominate during the forecast period?
  • How pharma players are taking opportunity of connected inhalers to improve drug sales?
  • How will pharma industry evolve in terms of drug-based devices in the future?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • Which are the key manufacturers in global digital respiratory devices market, and what are their contributions?

Global Digital Respiratory Devices Market Forecast, 2019-2029

The global digital respiratory devices market analysis done highlights that the market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.

The rise in the public awareness along with the reduced cost and technological advancements is responsible for bolstering the industry demand and aiding in reduction of the global healthcare expenditure. Furthermore, the recent developments in the regulatory pathway for the utilization of digital-based medical devices for medical and research purposes have increased the acceptance of digital respiratory devices.

In recent times, the increased prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), is considered to be one of the leading causes of mortality. With the increasing life span and life expectancy, the geriatric population is growing at a fast pace and is expected to witness a surge in the future.

Expert Quote on Global Digital Respiratory Devices Market

“North America is currently the leading contributor to the global digital respiratory devices market. The market was valued at $5.0 million in 2018. Factors such as availability of large number of key players, increasing healthcare infrastructure, high adoption rate for advanced technologies, and faster product approvals by the regulatory bodies in the region are driving the growth of the North American global digital respiratory devices market. However, the Rest-of-the-World is expected to register the highest CAGR, during the forecast period 2019-2029”.

Scope of the Market Intelligent on the Global Digital Respiratory Devices Market

The purpose of the global digital respiratory devices market study is to gain a holistic view of the market in terms of various factors influencing it, such as recent trends and technological advancements in the market. The scope of this report is centered upon conducting a detailed study of the products allied with the digital respiratory devices market, which include sensors, apps, smart inhalers, and nebulizers.

The global digital respiratory devices market is segmented into three different parts, namely, by product-type, by application, and by region. The global market value was estimated on the basis of these three different approaches which were validated against one another. These segments are further sub-segmented to ease the market estimation.

Market Segmentation

With the increasing demand for personalized medicine, increasing incidence of chronic and respiratory diseases, technological advancements in respiratory devices industry, and new product launches by several conglomerate companies, the global digital respiratory devices market is expected to witness high growth. Moreover, the sensors and apps sub-segment dominated the global digital respiratory devices market in 2018 in terms of products. However, the smart inhalers and nebulizers segment is anticipated to witness the highest CAGR in the forecast period from 2019 to 2029.

The global digital respiratory devices market is segmented on the basis of geographical regions into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). North America is the leading contributor in the global digital respiratory devices market. However, the Rest-of-the-World is expected to grow at a CAGR of 45.78% in the forecast period 2019-2029.

Key Companies in the Global Digital Respiratory Devices Market

The key players who have significant contributions to the digital respiratory devices market include 3M Health Care Limited, Adherium Limited, Capsule Technologies, Inc., Cohero Health, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries Ltd., Amiko Digital Health Limited, AstraZeneca plc, Boehringer Ingelheim International GmbH, and GlaxoSmithKline plc among others.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 3M Health Care Limited
  • Adherium Limited
  • AstraZeneca plc
  • Cohero Health
  • GlaxoSmithKline plc
  • Novartis AG
  • MORE

Executive Summary

1 Market Overview
1.1 Introduction
1.2 Digital Respiratory Devices Market Ecosystem
1.3 Assumptions and Limitations

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Increasing Prevalence of Respiratory Diseases
2.2.2 Increasing Adoption of Digital Technology Among Individuals
2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals
2.3 Market Restraints
2.3.1 Issues Related to The Accuracy and Reliability of the Device
2.3.2 Availability and High Cost Associated with Digital Respiratory Devices
2.4 Market Opportunities
2.4.1 Expansion into the Emerging Markets
2.4.2 Predicting Future Exacerbations

3 Competitive Landscape
3.1 Key Developments and Strategies
3.1.1 Agreements and Collaborations
3.1.2 Product Approvals
3.1.3 Mergers and Acquisitions
3.1.4 Awards and Recognitions
3.1.5 Investments, Funding, and Business Expansion
3.1.6 Product Launches
3.2 Market Share Analysis
3.3 Industry Attractiveness
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyer
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitute Products
3.3.5 Intensity of Competitive Rivalry

4 Industry Insights
4.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers
4.2 Smart Inhaler Value Propositions for Stakeholders
4.3 Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
4.4 Business Models for Digital Respiratory Devices Market

5 Global Digital Respiratory Devices Market (by Product Type)
5.1 Sensors and Apps
5.2 Smart Inhalers and Nebulizers

6 Global Digital Respiratory Devices Market (by Indication)
6.1 Asthma
6.2 Chronic Obstructive Pulmonary Disease (COPD)

7 Global Digital Respiratory Devices Market (by Region)
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 U.K.
7.2.3 France
7.2.4 Rest-of-Europe
7.3 Asia-Pacific (APAC)
7.3.1 Japan
7.3.2 China
7.3.3 Australia
7.3.4 India
7.3.5 Rest-of-Asia-Pacific (RoAPAC)
7.3.6 Rest-of-the-World (RoW)

8 Company Profiles
8.1 3M Health Care Limited
8.1.1 Company Overview
8.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market.
8.1.3 Financials
8.1.3.1 Key Insights on the Financial Health of the Company
8.1.4 SWOT Analysis
8.2 Adherium Limited
8.2.1 Company Overview
8.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market.
8.2.3 Financials
8.2.3.1 Key Insights on the Financial Health of the Company
8.2.4 SWOT Analysis
8.3 Amiko Digital Health Limited
8.3.1 Company Overview
8.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
8.3.3 SWOT Analysis
8.4 AstraZeneca plc
8.4.1 Company Overview
8.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
8.4.3 Financials
8.4.3.1 Key Insights on the Financial Health of the Company
8.4.4 SWOT Analysis
8.5 Boehringer Ingelheim International GmbH
8.5.1 Company overview
8.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
8.5.3 Financials
8.5.3.1 Key Insights on the Financial Health of the Company
8.5.4 SWOT Analysis
8.6 Capsule Technologies, Inc.
8.6.1 Company Overview
8.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
8.6.3 SWOT Analysis
8.7 Cohero Health
8.7.1 Company Overview
8.7.2 Role of Cohero Health in the Global Digital Respiratory Devices Market
8.7.3 SWOT Analysis
8.8 GlaxoSmithKline plc
8.8.1 Company overview
8.8.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
8.8.3 Financials
8.8.3.1 Key Insights on the Financial Health of the Company
8.8.4 SWOT Analysis
8.9 Novartis AG
8.9.1 Company overview
8.9.2 Role of Novartis AG in the Global Digital Respiratory Devices Market
8.9.3 Financials
8.9.3.1 Key Insights on the Financial Health of the Company
8.9.4 SWOT Analysis
8.10   Propeller Health
8.10.1 Company Overview
8.10.2 Role of Propeller Health in the Global Digital Respiratory Devices Market
8.10.3 SWOT Analysis
8.11   Sensiron AG
8.11.1 Company overview
8.11.2 Role of Sensiron AG in the Global Digital Respiratory Devices Market
8.11.3 Financials
8.11.3.1 Key Insights on the Financial Health of the Company
8.11.4 SWOT Analysis
8.12   Teva Pharmaceuticals Industries Ltd.
8.12.1 Company Overview
8.12.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
8.12.3 Financials
8.12.3.1 Key Insights on the Financial Health of the Company
8.12.4 SWOT Analysis

9 Research Scope and Methodology
9.1 Product Definition
9.2 Scope of the Research Study

List of Tables
Table 1: A Research and Facilitation Framework
Table 2: Impact Analysis of Global Digital Respiratory Devices Market
Table 2.1: Impact Analysis of Global Digital Respiratory Devices Market
Table 2.2: Prevalence of Asthma in Key Countries, 2015-2017
Table 2.3: Prevalence of COPD in Key Countries, 2015-2017
Table 4.1: Smart Inhaler Value Propositions for Stakeholders
Table 4.2: Different Data Revenue Streams
Table 5.1: Smart Inhalers in Pipeline
Table 6.1: Incidence of Asthma in Key Countries, 2015-2017
Table 6.2: Incidence of COPD in Key Countries, 2015-2017

List of Figures
Figure 1: Opportunities for Clinical Benefit
Figure 2: Global Digital Respiratory Devices Market, 2018-2029
Figure 3: Dominating Segments of Global Digital Respiratory Devices Market, 2018 and 2029
Figure 4: Global Digital Respiratory Devices Market (by Product Type), 2018 and 2029
Figure 5: Global Digital Respiratory Devices Market (by Indication), 2018 and 2029
Figure 6: Global Digital Respiratory Devices Market (by Region), 2018 and 2029
Figure 7: Strategies Incorporated to Expand the Global Reach
Figure 8: Go-To-Market Strategy
Figure 1.1: Digital Respiratory Devices Market Workflow
Figure 1.2: Smart Inhalers and Data Flow
Figure 1.3: Digital Respiratory Devices Market Ecosystem
Figure 3.1: Competitive Landscape, January 2015 - May 2019
Figure 3.2: Share of Key Developments and Strategies, January 2015- May 2019
Figure 3.3: Agreements and Collaborations Share (by Companies), January 2015- May 2019
Figure 3.4: Product Approvals Share (by Companies), January 2015- May 2019
Figure 3.5: Mergers and Acquisitions Share (by Companies), January 2015- May 2019
Figure 3.6: Awards and Recognitions Share (by Companies), January 2015- May 2019
Figure 3.7: Investments, Fundings, and Business Expansions Share (by Companies), January 2015- May 2019
Figure 3.8: Product Launches Share (by Companies), January 2015- May 2019
Figure 3.9: Market Share Analysis, 2017 and 2018
Figure 3.10: Porter’s Five Forces Analysis
Figure 3.11: Bargaining Power of Suppliers: Overall Impact, 2018-2029
Figure 3.12: Bargaining Power of Buyers: Overall Impact, 2018-2029
Figure 3.13: Threat of New Entrant: Overall Impact, 2018-2029
Figure 3.14: Threat of Substitute Products: Overall Impact, 2018-2029
Figure 3.15: Intensity of Competitive Rivalry: Overall Impact, 2018-2029
Figure 4.1: Opportunity Map Analysis of Digital Respiratory Devices Market
Figure 4.2: Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
Figure 5.1: Global Digital Respiratory Devices Market (by Product Type)
Figure 5.2: Global Digital Respiratory Devices Market Share (by Product Type), 2018 and 2029
Figure 5.3: Global Digital Respiratory Devices Market (by Sensors and Apps), 2018-2029
Figure 5.4: Global Digital Respiratory Devices Market (by Smart Inhalers and Nebulizers), 2018-2029
Figure 6.1: Global Digital Respiratory Devices Market (by Indication)
Figure 6.2: Global Digital Respiratory Devices Market Share (by Indication), 2018 and 2029
Figure 6.3: Global Digital Respiratory Devices Market (by Asthma), 2018-2029
Figure 6.4: Global Digital Respiratory Devices Market (by COPD), 2018-2029
Figure 7.1: Global Digital Respiratory Devices Market (by Region)
Figure 7.2: Global Digital Respiratory Devices Market (by Region), 2018-2029
Figure 7.3: North America Digital Respiratory Devices Market, 2018-2029
Figure 7.4: North America Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.5: U.S. Digital Respiratory Devices Market, 2018-2029
Figure 7.6: Canada Digital Respiratory Devices Market, 2018-2029
Figure 7.7: Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.8: Europe Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.9: Germany Digital Respiratory Devices Market, 2018-2029
Figure 7.10: U.K. Digital Respiratory Devices Market, 2018-2029
Figure 7.11: France Digital Respiratory Devices Market, 2018-2029
Figure 7.12: Rest-of-Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.13: Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.14: Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.15: Japan Digital Respiratory Devices Market, 2018-2029
Figure 7.16: China Digital Respiratory Devices Market, 2018-2029
Figure 7.17: Australia Digital Respiratory Devices Market, 2018-2029
Figure 7.18: India Digital Respiratory Devices Market, 2018-2029
Figure 7.19: Rest-of-Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.20: Rest-of-the-World Digital Respiratory Devices Market, 2018-2029
Figure 8.1: Shares of Key Company Profiles
Figure 8.2: Product Offerings for Global Digital Respiratory Devices Market
Figure 8.3: Overall Financials, 2016-2018
Figure 8.4: Net Revenue (by Business Segment), 2016-2018
Figure 8.5: Net Revenue (by Region), 2016-2018
Figure 8.6: R& D Expense, 2016-2018
Figure 8.7: Product Offerings for Global Digital Respiratory Devices Market
Figure 8.8: Overall Financials, 2016-2018
Figure 8.9: R&D Expense, 2016-2018
Figure 8.10: Amiko Digital Health Limited: Product Offerings
Figure 8.11: AstraZeneca plc: Product Offerings
Figure 8.12: AstraZeneca plc: Overall Financials, 2016-2018
Figure 8.13: AstraZeneca plc: Net Revenue (by Region), 2016-2018
Figure 8.14: AstraZeneca plc: R&D Expense, 2016-2018
Figure 8.15: Boehringer Ingelheim International GmbH: Product Offerings
Figure 8.16: Boehringer Ingelheim International GmbH: Overall Financials, 2016-2018
Figure 8.17: Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2016-2018
Figure 8.18: Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2016-2018
Figure 8.19: Boehringer Ingelheim International GmbH: R& D Expense, 2016-2018
Figure 8.20: Product Offerings for Global Digital Respiratory Devices Market
Figure 8.21: GlaxoSmithKline plc: Product Offerings
Figure 8.22: GlaxoSmithKline plc: Overall Financials, 2016-2018
Figure 8.23: GlaxoSmithKline plc Net Revenue (by Business Segment), 2016-2018
Figure 8.24: GlaxoSmithKline plc: Net Revenue (by Region), 2016-2018
Figure 8.25: GlaxoSmithKline plc: R& D Expense, 2016-2018
Figure 8.26: Novartis AG: Product Offerings
Figure 8.27: Novartis AG: Overall Financials, 2016-2018
Figure 8.28: Novartis AG Net Revenue (by Business Segment), 2016-2018
Figure 8.29: Novartis AG: Net Revenue (by Region), 2016-2018
Figure 8.30: Novartis AG: R& D Expense, 2016-2018
Figure 8.31: Propeller Health: Product Offerings for Digital Respiratory Devices Market
Figure 8.32: Product Offerings for Global Digital Respiratory Devices Market
Figure 8.33: Overall Financials, 2017-2018
Figure 8.34: Net Revenue (by Business Segment), 2017-2018
Figure 8.35: Net Revenue (by Region), 2017-2018
Figure 8.36: R&D Expense, 2016-2018
Figure 8.37: Product Offerings for Global Digital Respiratory Devices Market
Figure 8.38: Overall Financials, 2016-2018
Figure 8.39: Net Revenue (by Business Segment), 2017-2018
Figure 8.40: R&D Expense, 2016-2018
Figure 9.1: Global Digital Respiratory Devices Market Segmentation
Figure 9.2: Research Methodology
Figure 9.3: Primary Research
Figure 9.4: Secondary Research
Figure 9.5: Data Triangulation
Figure 9.6: Bottom-up Approach (Segment-wise Analysis)
Figure 9.7: Top-down Approach (Segment-wise Analysis)
Figure 9.8: Assumptions and Limitations
Figure 9.9: Considered Factors for Data Prediction and Modeling

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 3M Health Care Limited
  • Adherium Limited
  • AstraZeneca plc
  • Cohero Health
  • GlaxoSmithKline plc
  • Novartis AG
  • MORE

According to the new market intelligence report, titled “Global Digital Respiratory Devices Market”, the global digital respiratory devices market was estimated at $8.5 million in 2018, and is estimated to reach $334.0 million by 2029. The global digital respiratory devices market is expected to grow at a double-digit compound annual growth rate between 2018 and 2029, aided by the impressive growth in smart inhalers and nebulizers.

The global digital respiratory devices industry is facing increasing demand due to the increased awareness among individuals regarding the benefits of connected inhalers, substantial investments made in the field of personalized medicine, and growing adoption of sensor technologies and apps to monitor and manage inhalation of medications. Digital respiratory devices majorly focus on the advancements in information technology with respect to data integration, storage, and delivery and display of medical records and patient information properly. Ongoing product launches involving better technologies and faster recovery and increasing government and private funding in digital healthcare companies are some factors supporting the growth of the market. The  prevalence of respiratory diseases has increased at an alarming rate over the past 10 years, further leading to an increase in the need for early treatments for chronic respiratory diseases.

According to Wahid Khan, principal consultant, “North America is currently the leading contributor to the global digital respiratory devices market. The market was valued at $5.0 million in 2018. Factors such as availability of large number of key players, increasing healthcare infrastructure, high adoption rate for advanced technologies, and faster product approvals by the regulatory bodies in the region are driving the growth of the North American global digital respiratory devices market. However, the Rest-of-the-World is expected to register the highest CAGR of 45.78% during the forecast period 2019-2029”.

Research Highlights:

The emergence of global digital respiratory devices has enabled the increased utilization of the inhalers and nebulizers as a part of inhaled therapy for faster treatment of diseases. 

Currently, the smart inhalers and nebulizers segment is acknowledged to be the major contributor to the global digital respiratory devices market and is expected to grow at 61.40% CAGR during the forecast period 2019-2029.
The global digital respiratory devices test market comprises substantial investments made by several conglomerate and small-medium enterprises. More than 25 products from approximately 30 companies are available in the market.

Asthma in the application segment will be the major contributor for the sales of these products and is expected to witness a robust CAGR of 37.39% in the forecast period 2019-2029.
 
This market intelligence report provides a multidimensional view of the global digital respiratory devices market in terms of market size and growth potential. This research report aims at answering various aspects of the global digital respiratory devices market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions. The research report provides a comprehensive analysis of the product sales, manufacturers and trend analysis by segments, and demand analysis by regions.

This report is a meticulous compilation of research on more than 50 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of leading companies, market participants, and vendors. The key players who have significant contributions to the digital respiratory devices market are 3M Health Care Limited, Adherium Limited, Capsule Technologies, Inc., Cohero Health, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries Ltd., Amiko Digital Health Limited, AstraZeneca plc, Boehringer Ingelheim International GmbH, and GlaxoSmithKline plc among others.

Key questions answered in the report:

  • How pharma players are taking opportunity of connected inhalers to improve drug sales?
  • How will pharma industry evolve in terms of drug-based devices in the future?
  • What are the potential business models in global digital respiratory devices market?
  • What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?
  • What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?
  • What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2018?
  • How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2029?
  • What are the influencing factors that may affect the market share of the key players?
  • How is the industry expected to evolve during the forecast period 2019- 2029?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the key product types in the global digital respiratory devices market? What are the major benefits of each type?
  • What are the key applications in the global digital respiratory devices market? What are the major benefits of each type?
  • What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?
  • Which are the key manufacturers in global digital respiratory devices market, and what are their contributions?
Note: Product cover images may vary from those shown
5 of 6
  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies, Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Novartis AG
  • Propeller Health
  • Sensiron AG
  • Teva Pharmaceuticals Industries Ltd.
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll